BerandaAGIO • NASDAQ
add
Agios Pharmaceuticals Inc
Tutup sebelumnya
$27,19
Rentang hari
$26,25 - $27,00
Rentang tahun
$22,24 - $45,99
Kapitalisasi pasar
1,56Â M USD
Volume Rata-Rata
1,40Â jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 12,88Â jt | 43,69% |
Biaya operasional | 41,27Â jt | 7,10% |
Penghasilan bersih | -103,43Â jt | -110,91% |
Margin laba bersih | -803,05 | -107,59% |
Penghasilan per saham | -1,78 | -21,49% |
EBITDA | -115,50Â jt | -13,83% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 952,86Â jt | -5,17% |
Total aset | 1,39Â M | -22,66% |
Total liabilitas | 101,38Â jt | -38,61% |
Total ekuitas | 1,28 M | — |
Saham yang beredar | 58,31 jt | — |
Harga terhadap nilai buku | 1,23 | — |
Tingkat pengembalian aset | -20,45% | — |
Tingkat pengembalian modal | -21,27% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -103,43Â jt | -110,91% |
Kas dari operasi | -88,15Â jt | -4,67% |
Kas dari investasi | 95,56Â jt | -61,90% |
Kas dari pembiayaan | 4,44Â jt | 68,18% |
Perubahan kas bersih | 11,84Â jt | -93,00% |
Arus kas bebas | -56,62Â jt | -1.769,96% |
Tentang
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Didirikan
2008
Situs
Karyawan
487
